COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against...
Saved in:
Main Authors: | Awan K. Rahman, Adam G. Purdy, Peter T. Ender |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2020/8822753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Streptococcus pneumoniae Coinfection in COVID-19: A Series of Three Cases
by: Chaitanya Pal, et al.
Published: (2020-01-01) -
Granulomatosis with polyangiitis and COVID-19 pneumonia
by: Arvind Nune, et al.
Published: (2022-01-01) -
Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
by: Takashi Watari, et al.
Published: (2023-05-01) -
Spontaneous Pneumomediastinum Associated with COVID-19 Pneumonia
by: Hamza Mimouni, et al.
Published: (2020-01-01) -
Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia
by: Guohong Liu, et al.
Published: (2021-01-01)